Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53 target 3 family member G, pseudogene (TP53TG3GP), is a processed pseudogene listed in the human gene catalog. Pseudogenes such as TP53TG3GP arise from gene duplication or retrotransposition and typically do not encode functional proteins. TP53TG3GP belongs to a family of pseudogenes related to TP53, a well-known tumor suppressor gene, but unlike its protein-coding relatives, TP53TG3GP is neither expressed nor functional as a receptor, enzyme, or any other drug target. Its designation as a pseudogene means it does not participate in signal transduction, cell cycle regulation, or apoptosis nor is it a target for therapeutics, clinical biomarkers, or disease modulation. TP53TG3GP and closely related pseudogenes are sometimes identified in genomic analyses, but they are not active molecular targets and should not be confused with the canonical TP53 (p53), which is a major tumor suppressor and drug target. No evidence supports TP53TG3GP as a therapeutic target, and its mention in gene or protein databases primarily serves cataloging and evolutionary research purposes.
None (no established drug mechanism of action involving this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TP53 target 3 family member G, pseudogene (TP53TG3GP).